We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

346 hedge funds and large institutions have $7.99B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 120 increasing their positions, 112 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 112

2% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 94

1% less funds holding

Funds holding: 348 → 346 (-2)

24% less capital invested

Capital invested by funds: $10.6B → $7.99B (-$2.57B)

26% less funds holding in top 10

Funds holding in top 10: 19 → 14 (-5)

41% less call options, than puts

Call options by funds: $231M | Put options by funds: $389M

Holders
346
Holders Change
-2
Holders Change %
-0.57%
% of All Funds
9.23%
Holding in Top 10
14
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-26.32%
% of All Funds
0.37%
New
96
Increased
120
Reduced
112
Closed
94
Calls
$231M
Puts
$389M
Net Calls
-$158M
Net Calls Change
-$27.2M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$703M
2
JHIU
Janus Henderson Investors US
Colorado
+$181M
3
Morgan Stanley
Morgan Stanley
New York
+$156M
4
O
OppenheimerFunds
New York
+$143M
5
Invesco
Invesco
Georgia
+$109M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$496M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$489M
3
TCIM
TIAA CREF Investment Management
New York
-$159M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$119M
5
Citadel Advisors
Citadel Advisors
Florida
-$116M
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair & Company
276
William Blair & Company
Illinois
$510K -$29.7M -244,774 -98%
ST
277
Spot Trading
Illinois
$487K -$90K -743 -15%
WBC
278
Westpac Banking Corp
Australia
$448K +$473K +3,901 New
WSTAM
279
Wilbanks Smith & Thomas Asset Management
Virginia
$425K – – –
CD
280
Carl Domino
Florida
$402K +$424K +3,500 New
M&T Bank
281
M&T Bank
New York
$389K -$181K -1,493 -31%
DBG
282
De Burlo Group
Massachusetts
$379K -$9.56M -78,900 -96%
BCIM
283
British Columbia Investment Management
British Columbia, Canada
$378K +$399K +3,290 New
Marshall Wace
284
Marshall Wace
United Kingdom
$326K -$2M -16,531 -85%
US Bancorp
285
US Bancorp
Minnesota
$326K -$615K -5,078 -64%
BCM
286
Bienville Capital Management
New York
$322K +$339K +2,800 New
NBC
287
Neuberger Berman Canada
Ontario, Canada
$322K +$339K +2,800 New
DL
288
Delta Lloyd
Netherlands
$319K +$336K +2,777 New
HHMI
289
Howard Hughes Medical Institute
Maryland
$316K +$67.4K +556 +25%
Truist Financial
290
Truist Financial
North Carolina
$288K -$11.1K -92 -4%
ACM
291
Atika Capital Management
New York
$287K -$909K -7,500 -75%
CIM
292
Calvert Investment Management
Maryland
$275K +$6.18K +51 +2%
WSCM
293
Wellington Shields Capital Management
New York
$271K -$787K -6,495 -73%
SKK
294
Shepherd Kaplan Krochuk
Massachusetts
$268K +$282K +2,329 New
VKH
295
Virtu KCG Holdings
New York
$264K -$1.81M -14,901 -87%
KTC
296
Kistler-Tiffany Companies
Pennsylvania
$253K – – –
Mackenzie Financial
297
Mackenzie Financial
Ontario, Canada
$253K +$267K +2,200 New
AC
298
Addison Capital
Pennsylvania
$253K +$267K +2,201 New
SB
299
Suntrust Banks
Georgia
$243K -$16.1K -133 -6%
D.E. Shaw & Co
300
D.E. Shaw & Co
New York
$239K -$2.34M -19,304 -90%
10 11
12
13 14

SLXP Hedge Fund Activity: Q4 2014 in Review

346 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2014, worth a combined $7.99B — down 24% from $10.6B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new SLXP positions and 94 closed out — a net gain of 2 holders — while 120 added to existing stakes and 112 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $496M.

  • 346 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2014, down from 348 in Q3 2014.
  • Funds reported $7.99B of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2014, down 24% quarter-over-quarter.
  • 96 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2014 and 94 closed out, a net change of +2 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2014 was Paulson & Co, an estimated $703M added.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q4 2014 was Wellington Management Group, an estimated $496M sold.

Based on aggregated 13F filings for Q4 2014.